The effects of an angiotensin-converting inhibitor (Enalapril) on patients with mild cardiac failure - Evaluating cardiac function based on the relationship between daily walking pace and heart rate

Clinical Cardiology

Volumn 21, Issue 12, 1998, Pages 893-898

  Ino Oka, Eiji ^a,b   Umeda, Showko ^a   Kutsuwa, Yoshiharu ^a   Takahashi, Takashi ^a   Sagawa, Kouichi ^a   Takahashi, Takayuki ^a   Inooka, Hikaru ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Ohizumi Memorial Hospital   (Japan)

Author keywords

Cardiac function; Exercise heart rate response; Heart failure; Holter electrocardiogram; Walking pace heart rate relationship

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOSE RESPONSE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART RATE; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; WALKING;

EID: 0031742807     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960211207     Document Type: Article

References (33)

1. The Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Disease of the Heart and Great Vessels. 9th. ed., p. 253-256. Boston, Mass.: Little, Brown & Company, 1994
2. Goldman L, Hashimoto B, Cook EF, Loscalzo A: Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of new specific activity scale. Circulation 1981;64:1227-1234
3. Jafri SM, Lakier JB, Rosman HS, Peterson E, Goldstein S: Symptoms and tests of ventricular performance in the evaluation of chronic heart failure. Am Heart J 1986;112:194-196
4. Massie BM, Conway M: Survival of patients with congestive heart failure: Past, present and future prospects. Circulation 1987;75 (suppl):IV-11-IV-19
5. Likoff MI, Chandler SL, Key HR: Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1986;59:634-638
6. Packer M: Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure. Am J Cardiol 1989; 63:41A-45A
7. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-683
8. Uretsky BF, Jessup M, Konstam MA, Dei GW, Leier CV, Benotti J, Murali S, Hermann HC, Scandberg JA: Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure: Lack of benefit compared to placebo. Circulation 1990;82:774-780
9. Massie B, Bourassa M, Dibianco R, Hess M, Konstam M, Linkoff M, Packer M: Long-term oral administration of amrinone for congestive heart failure: Lack of efficacy in a multicenter controlled trial. Circulation 1985;71:963-971
10. Elkayam U, Amin J, Mehra A, Vasqez J, Weber L, Rahimtoola SH: A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-1961
11. Ino-Oka E, Takahashi T, Sagawa K, Inooka H: Diagnosis of silent myocardial ischemia using ambulatory electrocardiographic monitoring with pedometer, analysis of heart rate, and ST loop in ambulatory electrocardiogram. Clin Cardiol 1996;19:467-472
12. Yamanaka N, Sagawa K, Takahashi T, Ishihara M, Ino-Oka H, Takahashi T: Development of a long-term walk measuring system. Proc Symp Long-Term Imm Meas Anal of Phys Sig 1990;16: 217-220
13. Naganuma F, Kubota S, Hirahara N, Imai K, Kamiyama H, Iizuka T, Imai S, Murata K, Suzuki T: Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure. Jpn Circ J 1994;58:34-42
14. Brilla CG, Krämer B, Hoffmeister HM, Müller-Schauenburg W, Risler T, Seipel L: Low-dose enalapril in severe chronic heart failure. Cardiovasc Drug Ther 1989;3:211-218
15. Rector TS, Kubo SH, Cohn JN: Patients' self-assessment of their congestive heart failure: Part 2. Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987;3:198-209
16. Franciosa JA: Why patients with congestive heart failure die: Hemodynamic and functional determinants of survival. Circulation 1987;75(suppl):IV-20-IV-27
17. Packer M, Leiner CV: Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation 1987;75(suppl):IV-55-IV-63
18. Simonton CA, Daly PA, Kereiakes D, Modin G, Chatterjee K: Survival in severe left ventricular failure treated with the new non-glycosidic nonsympathomimetic oral inotropic agents. Chest 1989; 92:118-123
19. McGreger M, Klassen GA: Observations on the effect of heart rate on cardiac output in patients with complete heart block at rest and during exercise. Circ Res 1964;14/15(suppl II):II-215-II-224
20. Ikkos D, Hanson JS: Response in congenital complete atrioventricular block. Circulation 1960;22:583-590
21. Edhang O, Zetterquist S: Peripheral circulatory adaptation to exercise in restricted cardiac output. Scand J Clin Lab Invest 1968;21: 123-135
22. McElroy PA, Janicki JS, Weber KT: Physiologic correlation of the heart rate response to upright isotonic exercise: Relevance to rate-responsive pacemakers. J Am Coll Cardiol 1988;11:94-99
23. Reddy HK, McElroy PA, Janicki JS, Weber KT: Response in oxygen uptake and ventilation during stair climbing in patients with chronic heart failure. Am J Cardiol 1989;63:222-225
24. Insel J, Boland DM, Cinquegrani MJ: Acute haemodynamic effects of benazepril, a new oral long acting angiotensin converting enzyme inhibitor, in patients with severe congestive heart failure (abstr). Clin Res 1988;36:36A
25. Cohn JN: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310
26. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435
27. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302
28. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in symptomatic patients with reduced left ventricular ejection. N Engl J Med 1992;327:685-691
29. Pfeffer MA, Braunwald E: Effect of enalapril on mortality in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677
30. Colter HT, Ribner HS, Gradman A: Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. Am J Cardiol 1992;70:354-358
31. The Captopril Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. J Am Med Assoc 1988;259:539-544
32. Townend JN, Litler WA: Angiotensin converting enzyme inhibitors in heart failure: How good are they? Br Heart J 1993;69:373-375
33. Norderhaug JE, Vollset SE: Reduction of exercise induced ventricular arrhythmias in mild symptomatic heart failure by benazepril. Am Heart J 1993;125:771-776